Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Conley

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 7, 2022
Anti-phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with nasal polypsJacob G Eide, Jeffanie Wu, Whitney W Stevens, et al.
Immunity, Inflammation and Disease|May 6, 2017
Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polypsJulie A Poposki, Aiko I Klingler, Bruce K Tan, et al.
Journal of the American College of Radiology : JACR|November 6, 2017
ACR Appropriateness Criteria<sup>®</sup> Cranial Neuropathy, Bruno Policeni, Amanda S Corey, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2015
Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory DiseaseWhitney W Stevens, Christopher J Ocampo, Sergejs Berdnikovs, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2023
Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polypsBao-Feng Wang, Ping-Ping Cao, James E Norton, et al.
The Journal of Allergy and Clinical Immunology|October 28, 2017
IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cellsNoriko Ogasawara, Julie A Poposki, Aiko I Klingler, et al.
Journal of the American College of Radiology : JACR|May 6, 2019
ACR Appropriateness Criteria<sup>®</sup> Neck Mass-Adenopathy, Joseph M Aulino, Claudia F E Kirsch, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2025
Effects of type 3 and neutrophilic inflammation on type 2 chronic rhinosinusitis with nasal polypsAiko Oka, Aiko I Klingler, Masanori Kidoguchi, et al.
International Forum of Allergy & Rhinology|April 1, 2022
Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polypsAlexander L Schneider, Samuel D Racette, Anthony K Kang, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2015
Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal diseaseKathryn L Pothoven, James E Norton, Kathryn E Hulse, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 7, 2022
Anti-phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with nasal polypsJacob G Eide, Jeffanie Wu, Whitney W Stevens, et al.
Immunity, Inflammation and Disease|May 6, 2017
Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polypsJulie A Poposki, Aiko I Klingler, Bruce K Tan, et al.
Journal of the American College of Radiology : JACR|November 6, 2017
ACR Appropriateness Criteria<sup>®</sup> Cranial Neuropathy, Bruno Policeni, Amanda S Corey, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2015
Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory DiseaseWhitney W Stevens, Christopher J Ocampo, Sergejs Berdnikovs, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2023
Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polypsBao-Feng Wang, Ping-Ping Cao, James E Norton, et al.
The Journal of Allergy and Clinical Immunology|October 28, 2017
IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cellsNoriko Ogasawara, Julie A Poposki, Aiko I Klingler, et al.
Journal of the American College of Radiology : JACR|May 6, 2019
ACR Appropriateness Criteria<sup>®</sup> Neck Mass-Adenopathy, Joseph M Aulino, Claudia F E Kirsch, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2025
Effects of type 3 and neutrophilic inflammation on type 2 chronic rhinosinusitis with nasal polypsAiko Oka, Aiko I Klingler, Masanori Kidoguchi, et al.
International Forum of Allergy & Rhinology|April 1, 2022
Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polypsAlexander L Schneider, Samuel D Racette, Anthony K Kang, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2015
Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal diseaseKathryn L Pothoven, James E Norton, Kathryn E Hulse, et al.
Pageof 15